We are live on ! Find out more
NGVT icon

Ingevity

257 hedge funds and large institutions have $1.49B invested in Ingevity in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 92 increasing their positions, 75 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 75

6% more capital invested

Capital invested by funds: $1.4B → $1.49B (+$87.3M)

1.63% more ownership

Funds ownership: 99.02%100.66% (+1.6%)

0% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 34

2% less funds holding

Funds holding: 261257 (-4)

32% less call options, than puts

Call options by funds: $77K | Put options by funds: $114K

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
257
Holders Change
-4
Holders Change %
-1.53%
% of All Funds
3.39%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
34
Increased
92
Reduced
75
Closed
34
Calls
$77K
Puts
$114K
Net Calls
-$37K
Net Calls Change
-$72K

NGVT Hedge Fund Activity: Q4 2024 in Review

257 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Ingevity (NGVT) for Q4 2024, worth a combined $1.49B — up 6.2% from $1.4B a quarter earlier.

Fund positioning in NGVT was balanced in Q4 2024: 34 funds opened new positions, 34 closed out, 92 added to existing stakes and 75 trimmed.

The largest buyer was Maple Rock Capital Partners, opening a new position worth an estimated $17.9M. The largest seller was Glenmede Trust, cutting an estimated $11.7M.

  • 257 institutional investors held Ingevity (NGVT) as of Q4 2024, down from 261 in Q3 2024.
  • Funds reported $1.49B of Ingevity stock for Q4 2024, up 6.2% quarter-over-quarter.
  • 34 funds opened new Ingevity positions in Q4 2024 and 34 closed out, a net change of 0 holders.
  • The largest Ingevity buyer in Q4 2024 was Maple Rock Capital Partners, an estimated $17.9M added.
  • The largest Ingevity seller in Q4 2024 was Glenmede Trust, an estimated $11.7M sold.

Based on aggregated 13F filings for Q4 2024.